{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-248711","form_type":"8-K","ticker":"CRDF","cik":"0001213037","company_name":"Cardiff Oncology, Inc.","filed_at":"2026-05-29T21:11:12+00:00","discovered_at":"2026-05-29T21:12:00.208107+00:00","generated_at":"2026-05-29T21:12:30.664325+00:00","sec_items":["1.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"NMS terminates license agreement with Cardiff Oncology; Cardiff disputes termination","bullets":["NMS sent termination notice on May 27, 2026, citing alleged material breaches of the 2017 License Agreement.","NMS claims Cardiff failed to correct inventorship to include Dr. Barbara Valsasina on two U.S. patents and failed to use commercially reasonable efforts for onvansertib.","Cardiff filed a lawsuit on May 19, 2026, seeking injunctive relief and declaratory judgment that it did not breach the agreement.","Cardiff responded that the termination notice is legally ineffective and will continue to perform under the agreement.","Dispute centers on rights to onvansertib, a key pipeline asset; potential impact on development timeline."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-248711","json":"https://secwatch.observer/filing/0001193125-26-248711.json","markdown":"https://secwatch.observer/filing/0001193125-26-248711.md","text":"https://secwatch.observer/filing/0001193125-26-248711.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1213037/000119312526248711/0001193125-26-248711-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1213037/000119312526248711/crdf-20260527.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T21:12:30.664325+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001213900-26-061666","ticker":"NMHI","company_name":"Nature's Miracle Holding Inc.","filed_at":"2026-05-28T00:14:03+00:00","headline":"Nature's Miracle settles noteholder litigation for $575K; must reserve 222M shares","event_type":"litigation","sec_items":["1.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same SEC item: 1.01","same event type: litigation","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-061666","json":"https://secwatch.observer/filing/0001213900-26-061666.json","markdown":"https://secwatch.observer/filing/0001213900-26-061666.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1947861/000121390026061666/0001213900-26-061666-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1947861/000121390026061666/ea0292392-8k_natures.htm"},"side_by_side_evidence":null},{"accession":"0001628280-26-027280","ticker":"OPY","company_name":"OPPENHEIMER HOLDINGS INC","filed_at":"2026-04-27T23:59:59+00:00","headline":"Oppenheimer settles cash-sweep class action for $70M, to impact Q1 earnings","event_type":"litigation","sec_items":["1.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same SEC item: 1.01","same event type: litigation","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-027280","json":"https://secwatch.observer/filing/0001628280-26-027280.json","markdown":"https://secwatch.observer/filing/0001628280-26-027280.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/791963/000162828026027280/0001628280-26-027280-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/791963/000162828026027280/opy-20260424.htm"},"side_by_side_evidence":null},{"accession":"0001171843-26-002591","ticker":"AGAE","company_name":"Allied Gaming & Entertainment Inc.","filed_at":"2026-04-21T23:59:59+00:00","headline":"Allied Gaming settles litigation with Knighted for ~$5.94M paid over 3 months; CEO Li personally guarantees payment","event_type":"litigation","sec_items":["1.01","5.02","8.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same SEC item: 1.01","same event type: litigation","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-002591","json":"https://secwatch.observer/filing/0001171843-26-002591.json","markdown":"https://secwatch.observer/filing/0001171843-26-002591.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708341/000117184326002591/0001171843-26-002591-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708341/000117184326002591/f8k_042026.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-094084","ticker":"TRNR","company_name":"Interactive Strength, Inc.","filed_at":"2026-03-05T23:59:59+00:00","headline":"TRNR recovers $6.4M in full settlement of Sportstech loan dispute, ends legal proceedings","event_type":"litigation","sec_items":["1.01","8.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same SEC item: 1.01","same event type: litigation","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-094084","json":"https://secwatch.observer/filing/0001193125-26-094084.json","markdown":"https://secwatch.observer/filing/0001193125-26-094084.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1785056/000119312526094084/0001193125-26-094084-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1785056/000119312526094084/trnr-20260227.htm"},"side_by_side_evidence":null},{"accession":"0001682852-26-000047","ticker":"MRNA","company_name":"Moderna, Inc.","filed_at":"2026-03-05T23:59:59+00:00","headline":"Moderna settles all patent litigation with Arbutus/Genevant for $950M upfront, up to $1.3B contingent","event_type":"litigation","sec_items":["1.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same SEC item: 1.01","same event type: litigation","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001682852-26-000047","json":"https://secwatch.observer/filing/0001682852-26-000047.json","markdown":"https://secwatch.observer/filing/0001682852-26-000047.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000047/0001682852-26-000047-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000047/mrna-20260303.htm"},"side_by_side_evidence":null},{"accession":"0001140361-26-007548","ticker":"ROIV","company_name":"Roivant Sciences Ltd.","filed_at":"2026-03-03T23:59:59+00:00","headline":"Roivant's Genevant/Arbutus settles Moderna LNP patent suit for $950M upfront, plus $1.3B contingent","event_type":"litigation","sec_items":["1.01","7.01","8.01","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same SEC item: 1.01","same event type: litigation","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-007548","json":"https://secwatch.observer/filing/0001140361-26-007548.json","markdown":"https://secwatch.observer/filing/0001140361-26-007548.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1635088/000114036126007548/0001140361-26-007548-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1635088/000114036126007548/ef20067067_8k.htm"},"side_by_side_evidence":null},{"accession":"0001171843-26-001299","ticker":"ABUS","company_name":"Arbutus Biopharma Corp","filed_at":"2026-03-03T23:59:59+00:00","headline":"Arbutus/Genevant settle Moderna LNP patent litigation for $2.25B; $950M upfront due July 2026","event_type":"litigation","sec_items":["1.01","8.01","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same SEC item: 1.01","same event type: litigation","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-001299","json":"https://secwatch.observer/filing/0001171843-26-001299.json","markdown":"https://secwatch.observer/filing/0001171843-26-001299.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1447028/000117184326001299/0001171843-26-001299-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1447028/000117184326001299/f8k_030326.htm"},"side_by_side_evidence":null},{"accession":"0001466593-26-000057","ticker":"OTTR","company_name":"Otter Tail Corp","filed_at":"2026-05-29T14:47:20+00:00","headline":"Otter Tail settles two class claims in PVC pipe antitrust litigation for $73.5M","event_type":"litigation","sec_items":["1.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same SEC item: 1.01","same event type: litigation"],"urls":{"canonical":"https://secwatch.observer/filing/0001466593-26-000057","json":"https://secwatch.observer/filing/0001466593-26-000057.json","markdown":"https://secwatch.observer/filing/0001466593-26-000057.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1466593/000146659326000057/0001466593-26-000057-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1466593/000146659326000057/ottr-20260528.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}